ANXA1 was confirmed to participate in regulatory T cell (Treg)-mediated immune suppression in triple-negative breast cancer and can promote nasopharyngeal carcinoma growth and metastasis (38). Here, ANXA1 is linked to nasopharyngeal carcinoma.